Header cover image

U.S. Healthcare Sector Analysis

UpdatedFeb 28, 2024
DataAggregated Company Financials
Companies1420
  • 7D1.6%
  • 3M13.9%
  • 1Y13.8%
  • YTD6.4%

In the last week, the Healthcare industry is up 1.6%, with Eli Lilly up 2.6%. This takes the industry's 12 month performance to a gain of 14%. Looking forward, earnings are forecast to grow by 18% annually.

Sector Valuation and Performance

Has the U.S. Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 28 Feb 2024US$6.3tUS$2.8tUS$85.8b31x73.5x2.3x
Fri, 26 Jan 2024US$6.3tUS$2.8tUS$90.9b32x69.3x2.2x
Sun, 24 Dec 2023US$6.2tUS$2.8tUS$91.5b32.6x67.4x2.2x
Tue, 21 Nov 2023US$5.8tUS$2.8tUS$90.7b27.8x63.6x2x
Thu, 19 Oct 2023US$5.8tUS$2.8tUS$99.8b26x58.5x2.1x
Sat, 16 Sep 2023US$6.0tUS$2.8tUS$98.6b28.9x61.3x2.2x
Mon, 14 Aug 2023US$6.2tUS$2.8tUS$99.1b28.5x62.5x2.2x
Wed, 12 Jul 2023US$5.9tUS$2.7tUS$110.3b26.3x53.6x2.2x
Fri, 09 Jun 2023US$6.0tUS$2.7tUS$110.4b25.5x53.9x2.2x
Sun, 07 May 2023US$6.0tUS$2.7tUS$114.0b25x53x2.2x
Tue, 04 Apr 2023US$5.8tUS$2.5tUS$121.7b24.4x47.9x2.3x
Thu, 02 Mar 2023US$5.7tUS$2.5tUS$123.0b24.8x46.2x2.3x
Sat, 28 Jan 2023US$6.0tUS$2.5tUS$133.9b23.8x44.6x2.4x
Mon, 26 Dec 2022US$6.0tUS$2.5tUS$135.7b23x44.3x2.5x
Wed, 23 Nov 2022US$6.0tUS$2.4tUS$133.6b23.7x44.7x2.5x
Fri, 21 Oct 2022US$5.5tUS$2.4tUS$157.1b21.7x35.2x2.3x
Sun, 18 Sep 2022US$5.8tUS$2.4tUS$156.1b21.7x37x2.4x
Tue, 16 Aug 2022US$6.1tUS$2.4tUS$157.2b23.9x39x2.6x
Thu, 14 Jul 2022US$5.8tUS$2.6tUS$164.6b24.2x35.3x2.2x
Sat, 11 Jun 2022US$5.6tUS$2.6tUS$165.4b24.2x34x2.2x
Mon, 09 May 2022US$5.8tUS$2.6tUS$162.2b26x35.8x2.2x
Wed, 06 Apr 2022US$6.5tUS$2.5tUS$174.2b28.5x37.4x2.6x
Fri, 04 Mar 2022US$6.3tUS$2.5tUS$171.0b28.1x36.6x2.5x
Sun, 30 Jan 2022US$6.2tUS$2.4tUS$151.0b29.4x40.9x2.6x
Tue, 28 Dec 2021US$6.9tUS$2.4tUS$145.5b32.3x47.7x2.9x
Thu, 25 Nov 2021US$6.7tUS$2.4tUS$146.6b32.7x45.6x2.8x
Sat, 23 Oct 2021US$6.8tUS$2.3tUS$122.7b34.1x55.3x2.9x
Mon, 20 Sep 2021US$6.9tUS$2.3tUS$120.4b36.4x57.3x3x
Wed, 18 Aug 2021US$6.8tUS$2.3tUS$121.2b33.1x56.3x3x
Wed, 02 Jun 2021US$6.3tUS$2.4tUS$101.8b32.3x61.9x2.6x
Sat, 06 Mar 2021US$5.9tUS$2.3tUS$85.2b32.7x69.5x2.5x
Price to Earnings Ratio

69.5x


Total Market Cap: US$5.9tTotal Earnings: US$85.2bTotal Revenue: US$2.3tTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Healthcare Sector Price to Earnings3Y Average 50.6x202220232024
Current Industry PE
  • Investors are optimistic on the American Healthcare industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 73.5x which is higher than its 3-year average PE of 50.6x.
  • The industry is trading close to its 3-year average PS ratio of 2.4x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 5.8% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare sector?

US Market2.08%
Healthcare1.62%
Biotech4.73%
Healthtech2.62%
Life Sciences2.38%
Pharma1.48%
Medical Equipment0.45%
Healthcare Services-0.43%
Industry PE
  • Investors are most optimistic about the Pharma industry which is trading above its 3-year average PE ratio of 40.2x.
    • Analysts are expecting annual earnings growth of 21.1%, which is higher than its past year's earnings decline of 6.8% per year.
Forecasted Growth
  • Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 21% over the next 5 years.
  • This is better than its past earnings decline of 6.8% per year.
  • In contrast, the Healthcare Services industry is expected to see its earnings grow by 12% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
LLY Eli LillyUS$765.002.6%
+US$17.2b
143.5%PE131.4x
ABBV AbbVieUS$178.992.2%
+US$6.8b
15.3%PE65.6x
JNJ Johnson & JohnsonUS$160.981.4%
+US$5.5b
5.5%PE29.1x
VKTX Viking TherapeuticsUS$85.05141.8%
+US$5.0b
646.7%PB24.5x
ZTS ZoetisUS$199.005.6%
+US$4.9b
18.8%PE38.9x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

VKTX

US$85.05

Viking Therapeutics

7D

141.8%

1Y

646.7%

EXAS

US$56.90

Exact Sciences

7D

-10.1%

1Y

-8.9%

ABBV

US$178.99

AbbVie

7D

2.2%

1Y

15.3%

TFX

US$226.04

Teleflex

7D

-9.9%

1Y

-3.3%

REGN

US$993.35

Regeneron Pharmaceuticals

7D

4.3%

1Y

28.9%

PODD

US$166.62

Insulet

7D

-13.4%

1Y

-41.0%

GEHC

US$92.52

GE HealthCare Technologies

7D

8.9%

1Y

22.9%